Statistics for MEDNAX (id:9614 MD)

Valuation metrics

Market cap

1.22B

Enterprise value

1.66B

Trailing P/E (ttm)

7.98

Forward P/E

9.25

PEG ratio

9.25

Price/Sales (ttm)

0.61

Price/Book (mrq)

1.63

Enterprise Value/Revenue

0.83

Enterprise Value/EBITDA

8.34

Overview

Shares outstanding

85.88M

Float

74.98M

Shares short

3.94M

% Held by insiders

0.02%

% Held by institutions

1.06%

Average volume (10 days)

776.79K

Average volume (90 days)

Price summary

52-Week low

6.62

52-Week high

16.41

52-Week change

39.58%

Beta

1.56

50-Day moving average

12.53

200-Day moving average

9.67

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

December 20th, 2013

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-12.65%

Operating margin

10.26%

Operational effectiveness

Return on assets

4.67%

Return on equity

-29.86%

Income statement

Revenue (ttm)

24.17

Revenue per share (ttm)

24.17

Quarterly revenue growth (yoy)

-0.09

Gross profit (ttm)

421.56M

EBITDA

200.94M

Net income to common (ttm)

-253,836,000.00

Diluted EPS (ttm)

-2.34

Quarterly earnings growth (yoy)

-9.10%

Balance sheet

Total cash (mrq)

220.45M

Total cash per share (mrq)

2.61

Total debt (mrq)

683.65M

Total Debt/Equity (mrq)

93.33

Current ratio (mrq)

141.60%

Book value per share (mrq)

8.67

Cash flow

Cash flow statement

142.81M

Levered free cash flow (LFCF)

107.29M